Kevin Baranger, Ph.D
Affiliations: | Université de la Méditerranée, Marseille, Provence-Alpes-Côte d'Azur, France |
Google:
"Kevin Baranger"Mean distance: 106866
Collaborators
Sign in to add collaborator| Yannick Marchalant | collaborator | 2010-2014 | Université de la Méditerranée |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Migliorati M, Manrique C, Rahrah M, et al. (2022) The Helico Maze Detects Early Impairment of Reference Memory at Three Months of Age in the 5XFAD Mouse Model of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad |
| Pilat D, Paumier JM, García-González L, et al. (2022) MT5-MMP promotes neuroinflammation, neuronal excitability and Aβ production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer's disease. Journal of Neuroinflammation. 19: 65 |
| García-González L, Paumier JM, Louis L, et al. (2021) MT5-MMP controls APP and β-CTF/C99 metabolism through proteolytic-dependent and -independent mechanisms relevant for Alzheimer's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 35: e21727 |
| Zipfel P, Rochais C, Baranger K, et al. (2020) Matrix Metalloproteinases as New Targets in Alzheimer's Disease: Opportunities and Challenges. Journal of Medicinal Chemistry |
| Rochais C, Lecoutey C, Hamidouche K, et al. (2019) Donecopride, a Swiss army knife with potential interest against Alzheimer's disease. British Journal of Pharmacology |
| García-González L, Pilat D, Baranger K, et al. (2019) Emerging Alternative Proteinases in APP Metabolism and Alzheimer's Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP. Frontiers in Aging Neuroscience. 11: 244 |
| Baranger K, van Gijsel-Bonnello M, Stephan D, et al. (2019) Long-Term Pantethine Treatment Counteracts Pathologic Gene Dysregulation and Decreases Alzheimer's Disease Pathogenesis in a Transgenic Mouse Model. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics |
| Rivera S, García-González L, Khrestchatisky M, et al. (2019) Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders. Cellular and Molecular Life Sciences : Cmls |
| Paumier JM, Py NA, García-González L, et al. (2018) Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201801076R |
| Morello M, Landel V, Lacassagne E, et al. (2018) Vitamin D Improves Neurogenesis and Cognition in a Mouse Model of Alzheimer's Disease. Molecular Neurobiology |